Rønnevik P K, Nordrehaug J E, von der Lippe G
Department of Heart Disease, University Clinic Haukeland Hospital, Bergen, Norway.
Eur J Clin Pharmacol. 1995;48(2):127-31. doi: 10.1007/BF00192737.
The effects of the beta 1-selective beta-adrenergic blocker metoprolol on physiological responses, exercise capacity and gas exchange parameters were measured in healthy men using different graded bicycle exercise protocols on separate days before and following administration of 200 mg controlled-release metoprolol. Eleven men performed in randomised order maximal cardiopulmonary exercise testing on 50-W/6-min stage, 50-W/3-min stage and ramp (15-W/min-1) protocols. Peak heart rate and peak heart rate-blood pressure products were similar on all exercise protocols, and were significantly reduced by metoprolol. Submaximal and peak oxygen consumption were similar before and following beta-adrenoceptor blockade. Depending on the exercise protocol applied, an insignificant decrease of 4-10% in maximal cumulated exercise capacity (work-rate x time integral) was observed following administration of metoprolol. It is concluded that in healthy men evaluated with different exercise protocols the beta 1-selective controlled-release beta-adrenoceptor blocker metoprolol does not influence exercise capacity despite a marked reduction of heart rate and rate-pressure product.
在健康男性中,于服用200毫克缓释美托洛尔之前及之后的不同日期,采用不同的分级自行车运动方案,测量β1选择性β肾上腺素能阻滞剂美托洛尔对生理反应、运动能力和气体交换参数的影响。11名男性按照随机顺序在50瓦/6分钟阶段、50瓦/3分钟阶段和斜坡(15瓦/分钟-1)方案下进行了最大心肺运动测试。在所有运动方案中,峰值心率和峰值心率-血压乘积相似,且美托洛尔使其显著降低。在β肾上腺素能受体阻断前后,次最大耗氧量和峰值耗氧量相似。根据所应用的运动方案,服用美托洛尔后观察到最大累积运动能力(功率×时间积分)有4%-10%的不显著下降。结论是,在采用不同运动方案评估的健康男性中,β1选择性缓释β肾上腺素能阻滞剂美托洛尔尽管使心率和心率-血压乘积显著降低,但并不影响运动能力。